Table 1.
Summary of collected transcriptional and clinical data for AML LSC+, AML LSC-, and normal HSC+ samples
| GAL | CBX21 | GSE24006 | GSE30377 | GSE17054 | ETABM978 | GSM651554 | Group | |
|---|---|---|---|---|---|---|---|---|
| 1st author | Gal | Ishikawa F | Gentles AJ | Eppert K | Majeti R | Goardon N | Hu | |
| Journal | Leukemia | JAMA | JAMA leukemia | Nature Med | PNAS | Cancer Cell | Genome Res | |
| Year | 2006 | 2010 | 2011 | 2011 | 2009 | 2011 | 2011 | |
| PMID | 17039238 | 17952057 | 21177505 | 21873988 | 19218430 | 21251617 | 21795385 | |
| Engraftment verification for LSC+ | N/A | (NOD/SCID/IL)2r gamma (null) (NSG) | N/A | NOD/ShiLtSz-SCID (NODSCID) | N/A | NOD/SCID or NSG | N/A | |
| AML LCS+ (CD34 + CD38- | 8 | 13 | LSC+ (n = 77) | |||||
| AML LCS+ (CD34-CD38-) | 3 | |||||||
| AML LCS+ (CD34-CD38+) | 1 | |||||||
| AML LCS+ (CD34 + CD38+) | 8 | |||||||
| AML LCS+ (Lin-CD34 + CD38-CD90-) | ||||||||
| AML LCS+ (Lin-CD34 + CD38-CD90-CD45RA+) | 22 | |||||||
| GMP-like AML LSC+ (Lin-CD34 + CD38 + CD123+/loCD110-CD45RA + CD45RA+) | 22 | |||||||
| AML leukemia progenitor cell + (LPC+) (hCD34 + hCD38+) | 5 | 8 | 5 | LSC- (n = 59) | ||||
| AML CMP+ (Lin-CD34 + CD38+) | 7 | 1 | 1 | |||||
| AML MPP+ (Lin-CD34 + CD38-CD90-CD45RA-) | 2 | |||||||
| AML Blasts (Lin-CD34-) | 7 | 23 | ||||||
| normal HSC+ (CD34 + CD133+) | 1 | normal HSC+ (n = 23) | ||||||
| normal HSC+ (Lin-CD34 + CD38-) | ||||||||
| normal HSC+ (Lin-CD34 + CD38-) | ||||||||
| normal HSC+ (Lin-CD34 + CD38loCD36-) | ||||||||
| normal HSC+ (Lin-CD34 + CD38-CD90+) | 4 | |||||||
| normal HSC+ (Lin-CD34 + CD38-CD90 + CD45RA-) | 7 | 5 |